CPHA Canvax

"The purpose of this statement is to provide the current available scientific knowledge on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age." - Recommendation on the use of mRNA COVID-19 vaccines in adolescents 12 to 17 years of age

Additional Resource: 

Rating See Comments Ratings

Category:

Program Planning and Delivery,Program Delivery and Evaluation,Clinics,Vaccine Safety and Development,Vaccine Safety,Sub Topics: Vaccine Safety and Development,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19,Vaccine Monitoring and Surveillance,Vaccine Monitoring,Specific Populations,Adolescents Program Planning and Delivery
Program Delivery and Evaluation
Clinics
Vaccine Safety and Development
Vaccine Safety
Sub Topics: Vaccine Safety and Development
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19
Vaccine Monitoring and Surveillance
Vaccine Monitoring
Specific Populations
Adolescents

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.